Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Bioinformatics (Oxford, England)
|
July 7, 2016
SIFORM: shared informative factor models for integration of multi-platform bioinformatic data
Xuebei An, Jianhua Hu, Kim-Anh Do
BMC Medical Informatics and Decision Making
|
April 9, 2014
A simulation model of colorectal cancer surveillance and recurrence
Johnie Rose, Knut Magne Augestad, Chung Yin Kong, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 22, 2022
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial
Aliya A Khan, Mishaela R Rubin, Peter Schwarz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 8, 2024
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial
Bart L Clarke, Aliya A Khan, Mishaela R Rubin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2020
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
Nancy U Lin, Virginia Borges, Carey Anders, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Bioinformatics (Oxford, England)
|
July 7, 2016
SIFORM: shared informative factor models for integration of multi-platform bioinformatic data
Xuebei An, Jianhua Hu, Kim-Anh Do
BMC Medical Informatics and Decision Making
|
April 9, 2014
A simulation model of colorectal cancer surveillance and recurrence
Johnie Rose, Knut Magne Augestad, Chung Yin Kong, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 22, 2022
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial
Aliya A Khan, Mishaela R Rubin, Peter Schwarz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 8, 2024
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial
Bart L Clarke, Aliya A Khan, Mishaela R Rubin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2020
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
Nancy U Lin, Virginia Borges, Carey Anders, et al.
Page
of 1